Unclaimed brand
The Centre for Commercialization of Regenerative Medicine (CCRM) Nordic is located at GoCo Health Innovation City in Mölndal, Gothenburg, Sweden with specialized infrastructure and expertise focused on development, manufacturing and commercialization of Advanced Therapy Medicinal Products (ATMPs). ATMP is the European Medicines Agency (EMA) classification of cell and gene therapy drugs, and tissue engineered drugs. These products must be produced to Good Manufacturing Practice (GMP) standards and complete clinical trials before applying for market approval and becoming available to patients. Organizations like CCRM ensure ATMPs are manufactured and controlled according to the required quality standards, strengthening the chances these novel therapeutics will make it to patients. CCRM Nordic is a not-for-profit infrastructure for commercialization of advanced therapies, based on the successful CCRM model founded in Toronto, Canada and formed as a public private partnership backed by an industry consortium and the Swedish Innovation agency Vinnova.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#36A3DC
Curious Blue
54, 163, 220
201, 70, 54
75, 26, 0, 14
#233961
Cello
35, 57, 97
219, 47, 26
64, 41, 0, 62
#FECDA5
Flesh
254, 205, 165
27, 98, 82
0, 19, 35, 0
CCRM Nordic is a not-for-profit organization based in Gothenburg, Sweden, supporting innovators across the Nordics and Europe. It works to overcome bottlenecks in the translation and commercialization of advanced therapy medicinal products (ATMPs), helping academic teams and companies move promising therapies toward patients and the market.
Its services span key stages of development. CCRM Nordic provides CMC strategy support, process and analytical development, and fee-for-service analytical testing. It also offers market and intellectual property analysis, commercial strategy, and support for company creation and financing, including incubating selected technologies and helping attract capital. Projects can engage through fee-for-service work, in-kind collaboration or grant partnerships.
CCRM Nordic is developing purpose-built GMP and process development facilities, scheduled to open in Q2 2027. The organization plans to expand its analytical offering to full quality-control capabilities from Q1 2027. As a public-private partnership backed by industry organizations and Sweden’s innovation agency Vinnova, CCRM Nordic combines specialist expertise, infrastructure and collaboration to support the development of advanced therapies.
Company type
Nonprofit
Year founded
2023
Company size
2-10 employees